Fecal Microbiota Transplantation & Cardiometabolic Syndrome & Obesity

Fecal microbiota transplantation in metabolic syndrome: History, present and future.

Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation.

Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.

Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome.

Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review.

Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?

The Gut Microbiome and Obesity.

Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome.

Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes.

Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials.

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.

The gut microbiome and metabolic syndrome.

The Intestinal Microbiota in Metabolic Disease.

[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].

Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).

Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.

Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism.

Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.

Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation.

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota.

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.

Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome.

The Transplantation of omega3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders.

Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice.

Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases.

Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives.

Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice.

Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota.

IMPLICATION OF GUT MICROBIOTA IN DIABETES MELLITUS AND OBESITY.

Helminth-Induced and Th2-Dependent Alterations of the Gut Microbiota Attenuate Obesity Caused by High-Fat Diet.

The triterpenoid sapogenin (2alpha-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR/GLP-1 axis through gut microbiota remodelling.

Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice.

Regulation of Microbiota by Vitamin D Receptor: A Nuclear Weapon in Metabolic Diseases.

Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice.

Ephedra-Treated Donor-Derived Gut Microbiota Transplantation Ameliorates High Fat Diet-Induced Obesity in Rats.

[Faecal transplantation as a treatment for Clostridium difficile infection, ulcerative colitis and the metabolic syndrome].

Host Genetic Background and Gut Microbiota Contribute to Differential Metabolic Responses to Fructose Consumption in Mice.

Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity.

Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.

[Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].

An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota.

Reproductive and Behavior Dysfunction Induced by Maternal Androgen Exposure and Obesity Is Likely Not Gut Microbiome-Mediated.

Protective effects of tuna meat oligopeptides (TMOP) supplementation on hyperuricemia and associated renal inflammation mediated by gut microbiota.

Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice.

Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis.